Albiflorin reduces cerebral infarction, inhibits brain cell apoptosis, oxidative stress, and inflammation, and protects against nerve injury, possibly through activating the phosphatidylinositol 3‐kinase/protein kinase B/mammalian target of the rapamycin (PI3K/Akt/mTOR) signaling pathway. Here, MTOR is linked to cerebral infarction.